SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (2354)2/14/1998 6:00:00 PM
From: Bruce Rosen  Read Replies (1) of 7041
 
Capital Research and Development, manager of the American Funds family, filed last week that they own 700,000 shares of Zonagen in their Smallcap World fund. We already know that Putnam, Franklin and T Rowe Price have positions in Zonagen.

Perhaps some are underestimating the potential degree of institutional interest in Zonagen. There may be more such filings in the not too distant future.

I look forward to Bill's report of his visit to next week's Texas Biotechnology Conference. That is, if he can tear himself away from his computer.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News